589.48
前日終値:
$598.16
開ける:
$602.35
24時間の取引高:
1.44M
Relative Volume:
1.27
時価総額:
$61.41B
収益:
$14.21B
当期純損益:
$4.46B
株価収益率:
14.86
EPS:
39.68
ネットキャッシュフロー:
$3.56B
1週間 パフォーマンス:
+1.56%
1か月 パフォーマンス:
+5.09%
6か月 パフォーマンス:
-15.83%
1年 パフォーマンス:
-50.37%
Regeneron Pharmaceuticals Inc Stock (REGN) Company Profile
名前
Regeneron Pharmaceuticals Inc
セクター
電話
(914) 847-7000
住所
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
REGN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Regeneron Pharmaceuticals Inc Stock (REGN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-08-14 | 開始されました | Rothschild & Co Redburn | Buy |
2025-06-30 | ダウングレード | Argus | Buy → Hold |
2025-05-30 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
2025-05-30 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2025-05-14 | アップグレード | Citigroup | Neutral → Buy |
2025-04-22 | 再開されました | Cantor Fitzgerald | Overweight |
2025-02-05 | アップグレード | Leerink Partners | Market Perform → Outperform |
2025-01-16 | ダウングレード | UBS | Buy → Neutral |
2024-12-10 | 再開されました | BofA Securities | Underperform |
2024-11-15 | 開始されました | Wolfe Research | Outperform |
2024-11-14 | 開始されました | Citigroup | Neutral |
2024-09-24 | ダウングレード | Leerink Partners | Outperform → Market Perform |
2024-03-12 | 開始されました | Bernstein | Outperform |
2024-01-12 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2023-11-09 | 開始されました | Deutsche Bank | Hold |
2023-11-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
2023-08-21 | アップグレード | Canaccord Genuity | Hold → Buy |
2023-08-21 | 繰り返されました | Oppenheimer | Perform |
2023-06-28 | ダウングレード | Canaccord Genuity | Buy → Hold |
2023-03-27 | アップグレード | SVB Securities | Market Perform → Outperform |
2023-03-24 | アップグレード | Jefferies | Hold → Buy |
2023-03-23 | アップグレード | Raymond James | Underperform → Mkt Perform |
2023-01-30 | アップグレード | Cowen | Market Perform → Outperform |
2023-01-20 | アップグレード | JP Morgan | Neutral → Overweight |
2022-10-26 | ダウングレード | Raymond James | Mkt Perform → Underperform |
2022-10-17 | ダウングレード | Evercore ISI | Outperform → In-line |
2022-09-09 | アップグレード | Jefferies | Underperform → Hold |
2022-09-09 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2022-07-25 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2022-07-13 | 開始されました | Cantor Fitzgerald | Neutral |
2022-06-06 | 開始されました | Jefferies | Underperform |
2022-05-23 | 開始されました | SVB Leerink | Outperform |
2022-01-05 | ダウングレード | BofA Securities | Neutral → Underperform |
2022-01-03 | アップグレード | Bernstein | Mkt Perform → Outperform |
2021-12-15 | ダウングレード | Bernstein | Outperform → Mkt Perform |
2021-12-09 | 再開されました | Wells Fargo | Overweight |
2021-12-07 | 再開されました | Cowen | Market Perform |
2021-12-06 | 開始されました | Goldman | Buy |
2021-11-19 | 再開されました | BMO Capital Markets | Outperform |
2021-11-05 | ダウングレード | The Benchmark Company | Buy → Hold |
2021-06-29 | 開始されました | H.C. Wainwright | Buy |
2021-01-25 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
2021-01-13 | アップグレード | The Benchmark Company | Hold → Buy |
2021-01-08 | アップグレード | Citigroup | Neutral → Buy |
2020-10-05 | アップグレード | Cantor Fitzgerald | Neutral → Overweight |
2020-08-20 | ダウングレード | The Benchmark Company | Buy → Hold |
2020-07-09 | アップグレード | SunTrust | Hold → Buy |
2020-05-26 | アップグレード | Wells Fargo | Equal Weight → Overweight |
2020-04-28 | ダウングレード | Citigroup | Buy → Neutral |
2020-04-17 | アップグレード | The Benchmark Company | Hold → Buy |
2020-04-08 | 開始されました | The Benchmark Company | Hold |
2020-03-31 | 開始されました | Wolfe Research | Peer Perform |
2020-02-27 | 開始されました | Barclays | Overweight |
2020-02-26 | アップグレード | Canaccord Genuity | Hold → Buy |
2020-02-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2020-02-25 | アップグレード | Jefferies | Hold → Buy |
2020-02-11 | アップグレード | Argus | Hold → Buy |
2019-12-24 | 開始されました | Raymond James | Mkt Perform |
2019-12-16 | ダウングレード | Evercore ISI | Outperform → In-line |
2019-12-13 | アップグレード | Credit Suisse | Neutral → Outperform |
2019-11-12 | 開始されました | SunTrust | Hold |
2019-11-07 | アップグレード | Citigroup | Neutral → Buy |
2019-10-17 | 再開されました | BofA/Merrill | Neutral |
2019-09-23 | アップグレード | Guggenheim | Neutral → Buy |
すべてを表示
Regeneron Pharmaceuticals Inc (REGN) 最新ニュース
Regeneron Surges on FDA Delay as $0.77B Volume Ranks in Top 500 - AInvest
FDA Pushes Back Eylea HD Review; Regeneron Still Gains - Yahoo Finance
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Scholar Rock jumps following Regeneron Eylea update - Seeking Alpha
Element Capital Management LLC Purchases New Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron's Eylea injection review dates delayed by FDA (REGN) - Seeking Alpha
Aberdeen Group plc Acquires 56,746 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Fox Run Management L.L.C. Buys Shares of 1,734 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Announces FDA Extension for EYLEA HD® Regulatory Submissions to Q4 2025 - Quiver Quantitative
Regeneron Says FDA Will Take More Time to Review Its Two Eylea HD Submissions - Stocktwits
FDA Extends Review Timeline: Regeneron's EYLEA HD Faces Q4 2025 Decision for Expanded Uses - Stock Titan
RWA Wealth Partners LLC Decreases Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Qtron Investments LLC - MarketBeat
500 Shares in Regeneron Pharmaceuticals, Inc. $REGN Acquired by Corient IA LLC - MarketBeat
American Century Companies Inc. Purchases 14,921 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Independent Advisor Alliance Buys 472 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Public Sector Pension Investment Board - MarketBeat
Kovitz Investment Group Partners LLC Buys 3,090 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Cambiar Investors LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Ethic Inc. Cuts Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Bought by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat
Gulf International Bank UK Ltd Sells 2,097 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
National Pension Service Grows Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Sienna Gestion Has $5.65 Million Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Stock Slumps as Trading Volume Plunges 31% to 440M Ranking 207th in U.S. Activity - AInvest
85,929 Shares in Regeneron Pharmaceuticals, Inc. $REGN Purchased by Tocqueville Asset Management L.P. - MarketBeat
Leo Keeps On Profitable Path With Solid H1 Sales Growth - insights.citeline.com
Global Ophthalmology Drugs Market to Reach USD 26.28 Billion by 2030 | MarketsandMarkets™ - GlobeNewswire Inc.
State of New Jersey Common Pension Fund D Trims Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Dimensional Fund Advisors LP Sells 15,838 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals, Inc. $REGN Shares Sold by Prudential PLC - MarketBeat
Connor Clark & Lunn Investment Management Ltd. Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by E Fund Management Co. Ltd. - MarketBeat
1,038 Shares in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Bought by S Bank Fund Management Ltd - MarketBeat
Tokio Marine Asset Management Co. Ltd. Has $9.55 Million Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Russell Investments Group Ltd. Has $93.08 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Resona Asset Management Co. Ltd. Acquires 1,225 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
How volatile is Regeneron Pharmaceuticals Inc. stockTrade Volume Report & Technical Confirmation Alerts - thegnnews.com
Regeneron Pharmaceuticals (NASDAQ:REGN) Rating Increased to Strong-Buy at Redburn Atlantic - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Coverage Initiated at Rothschild & Co Redburn - MarketBeat
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Invesco Ltd. - MarketBeat
Regeneron Pharmaceuticals Inc. Building a Base Near SupportMarket Performance Summary & Growth Oriented Trading Recommendations - thegnnews.com
Cary Street Partners Financial LLC Sells 959 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron and Intellia’s Gene Therapy Study for Hemophilia B: A Potential Game Changer - TipRanks
Regeneron’s Phase 3 Study on Garetosmab: A Potential Game-Changer for FOP Treatment - TipRanks
Can Eylea HD and Dupixent Profits Revive Regeneron Stock? - Yahoo Finance
Mizuho Securities USA LLC Cuts Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $812.00 Price Target at Truist Financial - MarketBeat
Regeneron Pharmaceuticals Inc (REGN) 財務データ
収益
当期純利益
現金流量
EPS
Regeneron Pharmaceuticals Inc (REGN) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
McCourt Marion | EVP Commercial |
Nov 01 '24 |
Option Exercise |
381.40 |
1,000 |
381,400 |
13,931 |
McCourt Marion | EVP Commercial |
Nov 01 '24 |
Sale |
844.61 |
1,000 |
844,610 |
12,931 |
大文字化:
|
ボリューム (24 時間):